Delivery Order SPE2DB22D3016-SPE2DB24FBCZ1
Award Date
8/5/24
Potential Completion Date
8/26/24
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,960.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the drug product DARZALEX FASPRO 1,800MG-30,000 15ML, with a completion date of July 15, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,065.96 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $16,561.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is October 15, 2024. The award does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,043,988 units of the specialty drug DARZALEX FASPRO 1,800 MG - 30,000 15 ML. The contract is a firm-fixed price delivery order with a ceiling value of $5,520.42 and a performance period extending through October 29, 2024. As the prime contractor, Amerisourcebergen will be responsible for supplying this critical medication to support the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,881.26, is a Firm Fixed Price Delivery Order for the supply of 4,566,861,167 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 7, 2025. It is not designated as a...
This federal contract award, valued at $55,204.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Darzalex Faspro, a specialty medication, with an ultimate completion date of October 28, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for the supply of a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,892,614 units of the drug DARZALEX FASPRO 1,800MG-30,000 15ML. The $110,408.40 fixed-price contract was awarded on September 20, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. The contract has an ultimate completion date of October 11, 2024 and is not set aside for any specific business category....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,960.42 firm fixed-price delivery order is for the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a period of performance through July 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $38,642.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization that serves as the prime contractor. The award is a firm fixed price delivery order for the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. No set-aside designation was used. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...